Combination Targeted Treatment Approaches for Hidradenitis Suppurativa: A Comprehensive Review - Takeaways - MDSpire

Combination Targeted Treatment Approaches for Hidradenitis Suppurativa: A Comprehensive Review

  • By

  • Kenan Kherallah

  • Claire S. Chung

  • Raveena Ghanshani

  • Alexandra Charrow

  • Julia M. Riley

  • Christopher J. Sayed

  • Vivian Y. Shi

  • Katrina H. Lee

  • Jennifer L. Hsiao

  • November 24, 2025

  • 0 min

Share

  • 1

    Hidradenitis suppurativa (HS) is a chronic inflammatory disease with limited treatment options for patients unresponsive to single-agent biologic therapy.

  • 2

    Dual targeted therapy (DTT) is proposed as a promising strategy for HS, targeting multiple inflammatory pathways concurrently.

  • 3

    Current evidence for DTT in HS is limited to sparse case reports, all showing clinical improvement without serious short-term adverse events.

  • 4

    Experience from other immune-mediated diseases suggests that DTT can enhance treatment efficacy while maintaining acceptable safety profiles.

  • 5

    Further prospective long-term studies are necessary to evaluate the safety and efficacy of various DTT combinations for HS.

Original Source(s)

Combination Targeted Treatment Approaches for Hidradenitis Suppurativa: A Comprehensive Review

  • by Kenan Kherallah, Claire S. Chung, Raveena Ghanshani, Alexandra Charrow, Julia M. Riley, Christopher J. Sayed, Vivian Y. Shi, Katrina H. Lee, Jennifer L. Hsiao

  • November 24, 2025

Related Content

Psychiatric and Psychological Care Utilization Among Patients with Atopic Dermatitis, Hidradenitis Suppurativa, and Psoriasis: Insights from a Propensity-Matched Real-World Cohort Analysis

Mandatory Training Modules Deserve a Harder Look

A JAMA Viewpoint argues that 4 million physician-hours spent on compliance modules each year warrants institutional reassessment.

Dietary patterns, metabolic pathways and metainflammation in hidradenitis suppurativa: a systematic review